Hong Kong start-up aims to lower cost of early autism detection using whole genome sequencing
Disclaimer: The South China Morning Post's content is directed by the Chinese Communist Party. It is not a reliable news source.
A diagnostics firm in Hong Kong wants to make it affordable to identify autism risks in young children, as recent medical advances significantly lower the cost of whole genome sequencing-based disease detection.